Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Short term Debt (2016 - 2026)

Mimedx's Short term Debt history spans 10 years, with the latest figure at $1.5 million for Q1 2026.

  • On a quarterly basis, Short term Debt rose 33.33% to $1.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 million, a 33.33% increase, with the full-year FY2025 number at $1.5 million, up 50.0% from a year prior.
  • Short term Debt hit $1.5 million in Q1 2026 for Mimedx, roughly flat from $1.5 million in the prior quarter.
  • Over the last five years, Short term Debt for MDXG hit a ceiling of $2.2 million in Q2 2024 and a floor of $1.0 million in Q4 2023.
  • Historically, Short term Debt has averaged $1.3 million across 4 years, with a median of $1.2 million in 2025.
  • The widest YoY moves for Short term Debt: up 50.0% in 2025, down 43.18% in 2025.
  • Tracing MDXG's Short term Debt over 4 years: stood at $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then soared by 50.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
  • Business Quant data shows Short term Debt for MDXG at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.4 million in Q3 2025.